(We note, parenthetically, that the adjective “violent” describes our weather with unprecedented and escalating frequency – not that there is climate change, of course.) In a complementary fashion, defendants who win a few bellwether trials become less likely to settle the cases at all, or at least can justify offering a lower sum in damages.As we can now see, the entire process of Multi-District Litigation is geared toward shaping the conversations that take place in the conference room. Our experienced lawyers are ready to fight for your best interests. With this drug, it appears the hair loss is permanent, which is a side effect the company did not make known when the drug was put out on the market.While it may appear as though patients are overreacting to the side effect of permanent hair loss, they do not see it this way. 2740; In Re: Taxotere (Docetaxel) Products Liability Litigation) submitted a joint report indicating the increasing size of the litigation in the past months with more than 12,340 lawsuits pending against the defendant, Sanofi-Aventis. You must be an individual who is female and survived through either Stage I, II or III breast cancer. In important respects, MDL proceedings, despite being held in a centralized federal court, are still governed by a battery of state-based product liability laws. Although a preliminary discussion about a possible settlement got underway, no official statement has been released, yet. If you received Taxotere and experienced permanent or significant hair loss for longer than 6 months after chemotherapy, you may be entitled to financial compensation. In fact, Judge Engelhardt has already scheduled four of these initial trials, which are set to kick off in January 2019. Any side effect that occurs in between 1% and 10% of patients is considered “common” by the European regulatory body. Our house was built the same year we were built, and our yard, like the rest of the neighborhood, is dotted with mature and massive trees. Several Taxotere lawsuits are now scheduled against the manufacturer in 2020. Plaintiffs had ample time and opportunity to identify and present expert evidence supporting their argument that permanent hair loss should have been addressed in the ‘Warnings and Precautions’ section of the label. Patients using this drug experienced permanent hair loss, a side effect the company did not make known when the drug was put out on the market. Read 10 FAQs from breast cancer survivors.Facebook is showing information to help you better understand the purpose of a Page. And so the plaintiffs attempted to backpedal. 99 percent of them will get settled, which is how the drug manufacturer would like things to play out.So long as you have a solid case, and a good attorney at your side, getting a favorable settlement is definitely possible.There are requirements for bringing forward a claim.

The first bellwether that will go before a jury on January 11, 2019 will be selected from the claims filed by the Louisiana plaintiffs Lisa Tuyes, Barbara Earnest, Antoinette Durden, and Tanya Francis. The Product Lawyers were able to make the best out of my terrible situation.This news section covers all Taxotere-related news about settlements, lawsuits and the effect the drug has had on people who used it not knowing the full side effects.There have been more than 5,600 lawsuits filed against Sanofi-Aventis over the chemotherapy drug, Taxotere and the side effect of permanent hair loss. Initially 33 lawsuits from 25 districts were consolidated under the MDL in U.S. District Court for the Eastern District of Louisiana. Copyright © 2018 | The Product Lawyers - Sponsored by Justice Guardians, LLC - Attorney Advertising Taxotere (docetaxel) is a taxane chemotherapy drug that works by halting the division of cancer cells.

Taxotere, 2020 WL 2747278 at *1, *3. Taxotere is most often delivered in combination with other drugs, such as cisplatin, doxorubicin and fluorouracil. By clicking on or navigating the site, you agree to allow us to collect information on and off Facebook through cookies.

The first bellwether trial won’t be held until January 2019.But would it be smart to wait before filing a new case?

In her suit, she claims that while being treated for breast cancer in 2010 she was only informed that Taxotere could possibly cause temporary hair loss and in December 2015 the label was updated to include the side effect of possible